Mechanistic insights of Empagliflozin mediated cardiac benefits: Nearing the starting line
Gespeichert in:
| Veröffentlicht in: | Cardiovascular drugs and therapy 2017-06, Vol.31 (3), p.229-232 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 232 |
|---|---|
| container_issue | 3 |
| container_start_page | 229 |
| container_title | Cardiovascular drugs and therapy |
| container_volume | 31 |
| creator | Gupte, Manisha Umbarkar, Prachi Lal, Hind |
| description | |
| doi_str_mv | 10.1007/s10557-017-6741-2 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmedcentral</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5717761</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_5717761</sourcerecordid><originalsourceid>FETCH-LOGICAL-c231t-34ca93c79e434491eb1e89636caa7db053b65fed84215f5e8e11dc38d6fa15833</originalsourceid><addsrcrecordid>eNpVjsFKxDAYhIMo7rr6AN7yAtH8TdMkHgRZdlVY9aIXLyVN_7SRbro0UdCnd0UvnmaGjxmGkHPgF8C5ukzApVSMg2KVKoEVB2QOUgmmihIOyZybgjNR8GpGTlJ64_uOMfqYzAqthFBSz8nrA7rexpBycDTEFLo-Jzp6utrubDcEP4xfIdIttsFmbKmz09452mBEH3K6oo9opxA7mnukKdsp_4QhRDwlR94OCc_-dEFe1qvn5R3bPN3eL282zBUCMhOls0Y4ZbAUZWkAG0BtKlE5a1XbcCmaSnpsdVmA9BI1ArRO6LbyFqQWYkGuf3d3783-p8OYJzvUuyls7fRZjzbU_0kMfd2NH7VUoFQF4hseAGK2</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Mechanistic insights of Empagliflozin mediated cardiac benefits: Nearing the starting line</title><source>SpringerLink Journals - AutoHoldings</source><creator>Gupte, Manisha ; Umbarkar, Prachi ; Lal, Hind</creator><creatorcontrib>Gupte, Manisha ; Umbarkar, Prachi ; Lal, Hind</creatorcontrib><identifier>ISSN: 0920-3206</identifier><identifier>EISSN: 1573-7241</identifier><identifier>DOI: 10.1007/s10557-017-6741-2</identifier><identifier>PMID: 28733758</identifier><language>eng</language><ispartof>Cardiovascular drugs and therapy, 2017-06, Vol.31 (3), p.229-232</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c231t-34ca93c79e434491eb1e89636caa7db053b65fed84215f5e8e11dc38d6fa15833</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27923,27924</link.rule.ids></links><search><creatorcontrib>Gupte, Manisha</creatorcontrib><creatorcontrib>Umbarkar, Prachi</creatorcontrib><creatorcontrib>Lal, Hind</creatorcontrib><title>Mechanistic insights of Empagliflozin mediated cardiac benefits: Nearing the starting line</title><title>Cardiovascular drugs and therapy</title><issn>0920-3206</issn><issn>1573-7241</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpVjsFKxDAYhIMo7rr6AN7yAtH8TdMkHgRZdlVY9aIXLyVN_7SRbro0UdCnd0UvnmaGjxmGkHPgF8C5ukzApVSMg2KVKoEVB2QOUgmmihIOyZybgjNR8GpGTlJ64_uOMfqYzAqthFBSz8nrA7rexpBycDTEFLo-Jzp6utrubDcEP4xfIdIttsFmbKmz09452mBEH3K6oo9opxA7mnukKdsp_4QhRDwlR94OCc_-dEFe1qvn5R3bPN3eL282zBUCMhOls0Y4ZbAUZWkAG0BtKlE5a1XbcCmaSnpsdVmA9BI1ArRO6LbyFqQWYkGuf3d3783-p8OYJzvUuyls7fRZjzbU_0kMfd2NH7VUoFQF4hseAGK2</recordid><startdate>20170601</startdate><enddate>20170601</enddate><creator>Gupte, Manisha</creator><creator>Umbarkar, Prachi</creator><creator>Lal, Hind</creator><scope>5PM</scope></search><sort><creationdate>20170601</creationdate><title>Mechanistic insights of Empagliflozin mediated cardiac benefits: Nearing the starting line</title><author>Gupte, Manisha ; Umbarkar, Prachi ; Lal, Hind</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c231t-34ca93c79e434491eb1e89636caa7db053b65fed84215f5e8e11dc38d6fa15833</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gupte, Manisha</creatorcontrib><creatorcontrib>Umbarkar, Prachi</creatorcontrib><creatorcontrib>Lal, Hind</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cardiovascular drugs and therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gupte, Manisha</au><au>Umbarkar, Prachi</au><au>Lal, Hind</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mechanistic insights of Empagliflozin mediated cardiac benefits: Nearing the starting line</atitle><jtitle>Cardiovascular drugs and therapy</jtitle><date>2017-06-01</date><risdate>2017</risdate><volume>31</volume><issue>3</issue><spage>229</spage><epage>232</epage><pages>229-232</pages><issn>0920-3206</issn><eissn>1573-7241</eissn><pmid>28733758</pmid><doi>10.1007/s10557-017-6741-2</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0920-3206 |
| ispartof | Cardiovascular drugs and therapy, 2017-06, Vol.31 (3), p.229-232 |
| issn | 0920-3206 1573-7241 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5717761 |
| source | SpringerLink Journals - AutoHoldings |
| title | Mechanistic insights of Empagliflozin mediated cardiac benefits: Nearing the starting line |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T23%3A09%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mechanistic%20insights%20of%20Empagliflozin%20mediated%20cardiac%20benefits:%20Nearing%20the%20starting%20line&rft.jtitle=Cardiovascular%20drugs%20and%20therapy&rft.au=Gupte,%20Manisha&rft.date=2017-06-01&rft.volume=31&rft.issue=3&rft.spage=229&rft.epage=232&rft.pages=229-232&rft.issn=0920-3206&rft.eissn=1573-7241&rft_id=info:doi/10.1007/s10557-017-6741-2&rft_dat=%3Cpubmedcentral%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_5717761%3C/pubmedcentral%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/28733758&rfr_iscdi=true |